A share price of Maravai LifeSciences Holdings Inc [MRVI] is currently trading at $9.12, down -0.44%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MRVI shares have gain 9.35% over the last week, with a monthly amount glided 28.81%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Maravai LifeSciences Holdings Inc [NASDAQ: MRVI] stock has seen the most recent analyst activity on April 10, 2024, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $15. Previously, BofA Securities upgraded its rating to Buy on December 12, 2023, and dropped its price target to $8. On August 08, 2023, downgrade downgraded it’s rating to Sector Weight. Credit Suisse downgraded its rating to a Neutral and decreased its price target to $14 on May 23, 2023. Goldman downgraded its rating to a Neutral. UBS downgraded its rating to Neutral for this stock on January 05, 2023, and downed its price target to $16. In a note dated December 14, 2022, Deutsche Bank initiated an Buy rating and provided a target price of $25 on this stock.
Maravai LifeSciences Holdings Inc experienced fluctuations in its stock price throughout the past year between $4.52 and $12.10. Currently, Wall Street analysts expect the stock to reach $19 within the next 12 months. Maravai LifeSciences Holdings Inc [NASDAQ: MRVI] shares were valued at $9.12 at the most recent close of the market. An investor can expect a potential return of 108.33% based on the average MRVI price forecast.
Analyzing the MRVI fundamentals
Trailing Twelve Months sales for Maravai LifeSciences Holdings Inc [NASDAQ:MRVI] were 274.10M which represents -18.79% decline. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at -0.16%, Pretax Profit Margin comes in at 2.19%, and Net Profit Margin reading is -0.48%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.28 and Total Capital is -0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.29.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.93 points at the first support level, and at 8.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.31, and for the 2nd resistance point, it is at 9.50.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Maravai LifeSciences Holdings Inc [NASDAQ:MRVI] is 11.32. Also, the Quick Ratio is 10.47, while the Cash Ratio stands at 9.52. Considering the valuation of this stock, the price to sales ratio is 4.42, the price to book ratio is 2.95.
Transactions by insiders
Recent insider trading involved GTCR INVESTMENT XI LLC, Director, that happened on May 28 ’24 when 9.94 million shares were sold.
